Advertisement

Picture [iito] No Tracking 650x80px
Organisation › Details

Novartis AG (NYSE: NVS)

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 119,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. *

 

Period Start 1996-12-20 merged
  Group Novartis (Group)
Product Industry LIFE SCIENCES
Persons Person Narasimhan, Vasant (Vas) (Novartis 201408– Global Head Developm Novartis Pharma before Global Head Developm Vaccines
  Person 2 Reinhardt, Jörg (Novartis 201308– Board Chairman before Bayer 201008– CEO Bayer HealthCare AG before Novartis COO)
     
Region Region Basel BS
  Country Switzerland
  City 4002 Basel BS
  Tel 41 61 324 8000
    Address record changed: 2018-07-24
     
Basic data Employees J: more than 100,0 (2018-12-31)
  Currency USD
  Annual sales 47,498,000,000 (sales, net, continued operations, consolidated (2019) 2019-12-31)
  Profit 7,147,000,000 (2019-12-31)
  Cash 11,112,000,000 (2019-12-31)
     
    * Document for �About Section�: Novartis AG. (1/27/16). "Press Release: Novartis Delivered Strong Sales Growth and Core Margin Expansion (cc[1]) in 2015, Announces Plans to Accelerate Growth at Alcon, Streamline Group Operations". Basel.
     
   
Record changed: 2020-09-07

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Novartis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] Made Without Love 650x80px




» top